APA (7th ed.) Citation

Luzar, A. D., Otorepec, J., Košnik, M., Kopač, P., Šelb, J., Korošec, P., & Rijavec, M. Patients with detectable KIT p.D816V in peripheral blood are at high risk for adverse systemic events during venom immunotherapy and treatment failure. Wiley.

Chicago Style (17th ed.) Citation

Luzar, Ajda Demšar, Jakob Otorepec, Mitja Košnik, Peter Kopač, Julij Šelb, Peter Korošec, and Matija Rijavec. Patients with Detectable KIT P.D816V in Peripheral Blood Are at High Risk for Adverse Systemic Events During Venom Immunotherapy and Treatment Failure. Wiley.

MLA (9th ed.) Citation

Luzar, Ajda Demšar, et al. Patients with Detectable KIT P.D816V in Peripheral Blood Are at High Risk for Adverse Systemic Events During Venom Immunotherapy and Treatment Failure. Wiley.